Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-087914
Filing Date
2022-08-09
Accepted
2022-08-09 16:15:47
Documents
6
Period of Report
2022-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2222862d1_6k.htm 6-K 10846
2 EXHIBIT 99.1 tm2222862d1_ex99-1.htm EX-99.1 13084
3 EXHIBIT 99.2 tm2222862d1_ex99-2.htm EX-99.2 15456
4 GRAPHIC tm2222862d1_ex99-1img001.jpg GRAPHIC 10432
5 GRAPHIC tm2222862d1_ex99-1img002.jpg GRAPHIC 12008
6 GRAPHIC tm2222862d1_ex99-2img001.jpg GRAPHIC 10432
  Complete submission text file 0001104659-22-087914.txt   70007
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 221148502
SIC: 2833 Medicinal Chemicals & Botanical Products